Return to Article Details IN VITRO PREDICTION OF DRUG RELEASE PROFILE OF RIFAMPICIN IN CROHN’S DISEASE AND CHOLESTASIS DISEASE CONDITIONS USING BIOPHARMACEUTICAL TOOLS AND BIORELEVANT MEDIA Download Download PDF